{"nctId":"NCT00300755","briefTitle":"Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)","startDateStruct":{"date":"2006-05"},"conditions":["Gastroesophageal Reflux"],"count":60,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: pantoprazole sodium enteric-coated spheroid"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: pantoprazole sodium enteric-coated spheroid"]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: pantoprazole sodium enteric-coated spheroid"]}],"interventions":[{"name":"pantoprazole sodium enteric-coated spheroid","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ability to undergo endoscopy with required biopsy\n* Ages 1 through 5 years\n* Endoscopically confirmed GERD by positive endoscopic evidence of reflux related esophagitis or positive histologic evidence of esophagitis consistent with GERD Other inclusions apply.\n\nExclusion Criteria:\n\n* History or presence of upper gastrointestinal anatomic or motor disorders\n* Known current or active cow's milk allergy\n* Malignancy\n* Other exclusions apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","maximumAge":"5 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Weekly Gastroesophageal Reflux Disease (GERD) Symptom Scores (WGSS)","description":"WGSS is the sum of 5 selected individual weekly GERD mean frequency scores: vomiting/regurgitation, choking/gagging, refusal to eat, difficulty swallowing and abdominal/belly pain. Symptoms were assessed using a parent-administered questionnaire. The score for each individual symptom ranged from 0 (no symptoms) to 3 (highest frequency of symptoms), giving a WGSS range of 0-15. Change = score at week of assessment minus baseline score. Final week was defined as the last 7 days of symptom scores collected in the treatment period.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.89","spread":"1.41"},{"groupId":"OG001","value":"0.02","spread":"0.99"},{"groupId":"OG002","value":"-0.47","spread":"1.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.11","spread":"1.29"},{"groupId":"OG001","value":"-0.11","spread":"1.06"},{"groupId":"OG002","value":"-1.24","spread":"1.42"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.31","spread":"1.43"},{"groupId":"OG001","value":"-0.16","spread":"1.23"},{"groupId":"OG002","value":"-1.38","spread":"1.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.84","spread":"1.95"},{"groupId":"OG001","value":"-0.20","spread":"1.29"},{"groupId":"OG002","value":"-1.32","spread":"1.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.05","spread":"2.08"},{"groupId":"OG001","value":"-0.48","spread":"1.31"},{"groupId":"OG002","value":"-1.30","spread":"1.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.99","spread":"1.83"},{"groupId":"OG001","value":"-0.61","spread":"1.31"},{"groupId":"OG002","value":"-1.42","spread":"1.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.44","spread":"1.75"},{"groupId":"OG001","value":"-0.58","spread":"1.38"},{"groupId":"OG002","value":"-1.58","spread":"1.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.34","spread":"1.81"},{"groupId":"OG001","value":"-0.60","spread":"1.49"},{"groupId":"OG002","value":"-1.61","spread":"1.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.37","spread":"1.74"},{"groupId":"OG001","value":"-0.64","spread":"1.40"},{"groupId":"OG002","value":"-1.66","spread":"1.64"}]}]}]},{"type":"SECONDARY","title":"Change in Individual Weekly Mean Frequency Score for Each Gastroesophageal Reflux Disease (GERD) Symptom Score From Baseline to Final Week","description":"Selected symptoms of GERD were assessed using a parent-administered questionnaire. The score for each symptom ranged from 0 (no symptom) to 3 (highest frequency of symptom), The weekly mean score was the sum of daily scores that week, divided by the number of days with scores for that week. Change = final week score minus baseline score. Final week was defined as the last 7 days of scores collected in the treatment period.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.77","spread":"0.89"},{"groupId":"OG001","value":"-0.06","spread":"0.28"},{"groupId":"OG002","value":"-0.25","spread":"0.48"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.43","spread":"0.33"},{"groupId":"OG001","value":"-0.05","spread":"0.48"},{"groupId":"OG002","value":"-0.47","spread":"0.59"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.34","spread":"0.49"},{"groupId":"OG001","value":"-0.16","spread":"0.61"},{"groupId":"OG002","value":"-0.26","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.42","spread":"0.52"},{"groupId":"OG001","value":"-0.13","spread":"0.49"},{"groupId":"OG002","value":"-0.39","spread":"0.79"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.42","spread":"0.49"},{"groupId":"OG001","value":"-0.24","spread":"0.44"},{"groupId":"OG002","value":"-0.28","spread":"0.49"}]}]}]},{"type":"SECONDARY","title":"Change in Individual Weekly Mean Score For Each Respiratory Symptom From Baseline","description":"Individual respiratory symptoms weekly score was calculated as the average score / number of events for a patient in the corresponding week if the patient answered a question â‰¥3 times that week. Change = final week score minus baseline score. Final week was defined as the last 7 days of scores collected in the treatment period.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.11","spread":"0.41"},{"groupId":"OG001","value":"0.13","spread":"0.43"},{"groupId":"OG002","value":"0.11","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.38","spread":"0.34"},{"groupId":"OG001","value":"-0.20","spread":"0.38"},{"groupId":"OG002","value":"-0.24","spread":"0.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.48","spread":"0.97"},{"groupId":"OG001","value":"-0.19","spread":"0.35"},{"groupId":"OG002","value":"-0.16","spread":"0.36"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":"0.55"},{"groupId":"OG001","value":"-0.15","spread":"0.29"},{"groupId":"OG002","value":"-0.16","spread":"0.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.15","spread":"0.46"},{"groupId":"OG001","value":"-0.04","spread":"0.12"},{"groupId":"OG002","value":"-0.02","spread":"0.08"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":"0.49"},{"groupId":"OG001","value":"-0.16","spread":"0.30"},{"groupId":"OG002","value":"-0.16","spread":"0.31"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.09","spread":"0.30"},{"groupId":"OG001","value":"-0.03","spread":"0.11"},{"groupId":"OG002","value":"-0.13","spread":"0.32"}]}]}]},{"type":"SECONDARY","title":"Number of Patients With \"Healed\" Erosive Esophagitis (EE) at End of Study","description":"Healed EE was defined as a modified Hetzel-Dent (HD) score \\<2 on endoscopy at end of study. HD is a standardized rating scale for grading esophageal damage and severity of gastroesophageal reflux disease (GERD). HD score ranges from 0 (normal mucosa) to 4 (deep peptic ulceration).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"2","spread":null},{"groupId":"OG002","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Upper respiratory infection","Fever","Diarrhea","Vomiting","Rhinitis"]}}}